Numeric Investors’s Kite Pharma, Inc. KITE Stock Holding History

Numeric Investors’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-9,700	Closed	-$598K	–	1209
2015 Q4	$598K	Buy	+9,700	New	+$683K	0.01%	686
2015 Q2	–	Sell	-4,100	Closed	-$236K	–	1168
2015 Q1	$236K	Buy	+4,100	New	+$275K	﹤0.01%	771

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Numeric Investors's KITE Position: Q1 2016 in Review

Numeric Investors sold out of Kite Pharma, Inc. (KITE) in Q1 2016, closing a stake of 9,700 shares — an estimated $598K sold.

Numeric Investors first reported a position in KITE in Q1 2015 and held it in 2 quarters. The position peaked at $598K in Q4 2015. 171 funds tracked by Wall St. Rank hold KITE as of Q1 2016.

Numeric Investors reported no remaining Kite Pharma, Inc. position as of Q1 2016 after selling out during the quarter.
Numeric Investors sold 9,700 Kite Pharma, Inc. shares in Q1 2016, an estimated $598K.
Numeric Investors first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 2 quarters.
Numeric Investors's Kite Pharma, Inc. position peaked at $598K in Q4 2015.
171 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2016.

Based on Numeric Investors's 13F filing for Q1 2016, filed 6 May 2016.